These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3701607)

  • 1. Pharmacokinetics of pentaerythritol tetranitrate following intra-arterial and oral dosing in the rat.
    King SY; Fung HL
    J Pharm Sci; 1986 Mar; 75(3):247-50. PubMed ID: 3701607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid microbial degradation of organic nitrates in rat excreta. Re-examination of the urinary and fecal metabolite profiles of pentaerythritol tetranitrate in the rat.
    King SY; Fung HL
    Drug Metab Dispos; 1984; 12(3):353-7. PubMed ID: 6145563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Examination of the in vitro degradation of [14C] pentaerythritol tetranitrate in rat and human blood with an improved thin-layer radiochromatographic procedure.
    King SY; Fung HL
    J Chromatogr; 1985 Sep; 343(1):129-37. PubMed ID: 4066847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood levels of the metabolites of glyceryl trinitrate and pentaerythritol tetranitrate after administration of a two-step preparation.
    Neurath GB; Dünger M
    Arzneimittelforschung; 1977 Feb; 27(2):416-9. PubMed ID: 405020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentaerythritol tetranitrate and metabolites in rat plasma.
    Crew M; Melgar MD; Di Carlo FJ
    J Pharmacol Exp Ther; 1975 Jan; 192(1):218-223. PubMed ID: 1123725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentaerythritol trinitrate metabolism by the rat.
    DiCarlo FJ; Crew MC; Haynes LJ; Wilson M
    Biochem Pharmacol; 1969 Aug; 18(8):1985-90. PubMed ID: 4980468
    [No Abstract]   [Full Text] [Related]  

  • 7. Absorption, excretion and metabolism of pentaerythritol tetranitrate by humans.
    Davidson IW; Miller HS; DiCarlo FJ
    J Pharmacol Exp Ther; 1970 Oct; 175(1):42-50. PubMed ID: 5471451
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of nonintermittent treatment of rabbits with pentaerythritol tetranitrate on vascular reactivity and superoxide production.
    Kojda G; Hacker A; Noack E
    Eur J Pharmacol; 1998 Aug; 355(1):23-31. PubMed ID: 9754935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The absorption and biotransformation of pentaerythritol tetranitrate-1,2-14-C by rats.
    DiCarlo FJ; Crew MC; Coutinho CB; Haynes LJ; Sklow NJ
    Biochem Pharmacol; 1967 Feb; 16(2):309-16. PubMed ID: 6029916
    [No Abstract]   [Full Text] [Related]  

  • 10. The pharmacodynamics and biotransformation of pentaerythritol trinitrate in man.
    Davidson IW; Rollins FO; DiCarlo FJ; Miller HS
    Clin Pharmacol Ther; 1971; 12(6):972-81. PubMed ID: 5134999
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and tissue distribution of ketanserin in rat, rabbit and dog.
    Michiels M; Monbaliu J; Meuldermans W; Hendriks R; Geerts R; Woestenborghs R; Heykants J
    Arzneimittelforschung; 1988 Jun; 38(6):775-84. PubMed ID: 3178917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study of the plasma levels of pentaerythritol mononitrate following administration of pentaerythritol tetranitrate in combination with meprobamate and diphenhydramine.
    Gilbert JD; Aylott RI; Draffan GH; Sögtrop HH
    Arzneimittelforschung; 1982; 32(5):571-4. PubMed ID: 7201836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamics and biotransformation of pentaerythritol tetranitrate in man.
    Davidson IW; Miller HS; DiCarlo FJ
    J Pharm Sci; 1971 Feb; 60(2):274-7. PubMed ID: 5572454
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral and topical absorption, disposition kinetics, and the metabolic fate of trans-methyl styryl ketone in the male Fischer 344 rat.
    Sauer JM; Smith RL; Bao J; Kattnig MJ; Kuester RK; McClure TD; Mayersohn M; Sipes IG
    Drug Metab Dispos; 1997 Jun; 25(6):732-9. PubMed ID: 9193875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of pentaerythritol tetranitrate and its metabolites by rat blood plasma and erythrocytes.
    DiCarlo FJ; Coutinho CB; Sklow NJ; Haynes LJ; Crew MC
    Proc Soc Exp Biol Med; 1965 Dec; 120(3):705-9. PubMed ID: 5858694
    [No Abstract]   [Full Text] [Related]  

  • 16. The biotransformation of pentaerythritol tetranitrate as related to host defense reactions.
    DiCarlo FJ
    J Reticuloendothel Soc; 1967 May; 4(2):190-210. PubMed ID: 4964435
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetics of nitrate derivatives: recent data].
    Baligadoo S; Chiche P
    Coeur Med Interne; 1979; 18(2):263-8. PubMed ID: 114351
    [No Abstract]   [Full Text] [Related]  

  • 18. Pentaerythritol tetranitrate metabolism: a non-essential role for the flora.
    Carter JH; Goldman P
    Biochem Pharmacol; 1976 Apr; 25(7):860-2. PubMed ID: 938587
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained beneficial effects of oral pentaerythritol tetranitrate on ventricular function in chronic congestive heart failure.
    Shah PK; Shellock FG; Berman DS; Rubin SA; Singh BN; Swan HJ
    Nouv Presse Med; 1980 Sep; 9(34 Suppl):2447-50. PubMed ID: 7422534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption, distribution, metabolism, and excretion of N,N-diethyl-M-toluamide in the rat.
    Schoenig GP; Hartnagel RE; Osimitz TG; Llanso S
    Drug Metab Dispos; 1996 Feb; 24(2):156-63. PubMed ID: 8742226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.